CLINICAL_TRIALS
trial_result
· 2013-09-18
Clinical Trial Update: To Demonstrate Superiority of Decitabine Over Azacitidine in Subjects With Intermediate- or High-risk MDS. [Phase 4]
Summary
A Phase 4 trial comparing decitabine with azacitidine in intermediate- or high-risk myelodysplastic syndromes was terminated, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eisai Inc. | Conditions: Myelodysplastic Syndromes | Phase 4 | Status: TERMINATED | Results posted: 2013-09-18